A carregar...

Evaluation of inhibitor antibody in hemophiliaA population

Background: Inhibitor antibody to exogenous Factor VIII (FVIII) is a major complication of hemophilia treatment. This study was conducted to determine the prevalence of inhibitor antibody directed against FVIII. Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Ami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mahmoodi Nesheli, Hassan, Hadizadeh, Amereh, Bijani, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: Babol University of Medical Sciences 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755836/
https://ncbi.nlm.nih.gov/pubmed/24009969
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!